DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for ImmunoGen, Inc. (IMGN)
« Back to company indexIMGN Chatter Timeline
Stock Ticker for IMGN
Most Active Tweeters for IMGN
| User | Tweets |
|---|---|
| @FlashAlert_me | 6 |
| @Gambiste1 | 3 |
| @AmericanBanking | 3 |
| @StockPyf | 2 |
| @TopStockAlerts1 | 2 |
Recent Tweets for IMGN
 |
@StockPyf Take a look at this Watchlist: $IMGN $ZIOP This is a Filter ScannerAlert scnPennyADTM DateTime: 2019-07-15 09:40 ET July 15th 2019, 9:07am |
 |
@AmericanBanking ImmunoGen, Inc. $IMGN Given Consensus Recommendation of “Hold” by Analysts https://t.co/JrAqX762iG #stocks July 14th 2019, 2:07am |
|
@AmericanBanking -$0.32 Earnings Per Share Expected for ImmunoGen, Inc. $IMGN This Quarter https://t.co/XAmPUaAku9 #stocks July 13th 2019, 10:07am |
 |
@Gambiste1 RT @TekATL3: $IMGN may share. Currently got a small db above where a longer term db set would be, but holding up here atm https://t.co/pxr… July 13th 2019, 1:07am |
 |
@TekATL3 $IMGN may share. Currently got a small db above where a longer term db set would be, but holding up here atm https://t.co/pxrSQVb16t July 13th 2019, 1:07am |
|
@Gambiste1 RT @StockPyf: Take a look at this Watchlist: $IMGN This is a Filter ScannerAlert scnPennyADTM DateTime: 2019-07-12 10:25 ET July 12th 2019, 11:07am |
|
@StockPyf Take a look at this Watchlist: $IMGN This is a Filter ScannerAlert scnPennyADTM DateTime: 2019-07-12 10:25 ET July 12th 2019, 10:07am |
 |
@ez_alertz $IMGN Will ImmunoGen Continue to Surge Higher? https://t.co/krGXAM4LdU July 12th 2019, 9:07am |
 |
@dispatchtribune ImmunoGen $IMGN Upgraded by BidaskClub to “Sell” https://t.co/1xAnVu9FKv July 10th 2019, 2:07am |
 |
@ThisLincolnian ImmunoGen $IMGN Upgraded by BidaskClub to “Sell” https://t.co/i2TmWLlGdU July 10th 2019, 2:07am |
 |
@WeekHerald ImmunoGen $IMGN Upgraded to “Sell” by BidaskClub https://t.co/7bmaMDCOmu July 10th 2019, 2:07am |
 |
@ZolmaxNews ImmunoGen $IMGN Trading Up 7.4% https://t.co/FtR7Rf5rBZ July 9th 2019, 11:07pm |
 |
@TopStockAlerts1 $IMGN Liking it for a swing! https://t.co/ZKx6HyHoXo July 9th 2019, 12:07pm |
|
@AmericanBanking Weekly Research Analysts’ Ratings Changes for ImmunoGen $IMGN https://t.co/y9SgZduerU #stocks July 9th 2019, 4:07am |
 |
@macondailynews BidaskClub Upgrades ImmunoGen $IMGN to Sell https://t.co/WfIng26R30 July 9th 2019, 2:07am |
 |
@TheMarketsDaily ImmunoGen $IMGN Upgraded at BidaskClub https://t.co/l3THTRkuzo July 9th 2019, 2:07am |
 |
@OlympiaReport ImmunoGen $IMGN Stock Rating Upgraded by BidaskClub https://t.co/hNNMQZ485I July 8th 2019, 3:07am |
 |
@TickerReport ImmunoGen $IMGN Upgraded to “Sell” by BidaskClub https://t.co/TpdJD8FVVk July 7th 2019, 7:07am |
|
@TopStockAlerts1 $IMGN keep an eye on it! https://t.co/ZKx6HyHoXo July 5th 2019, 10:07pm |
 |
@TimCarmichael3 @BioStocks $IMGN is Immunogen — not $IMMU Immunomedics July 5th 2019, 6:07pm |
 |
@BeefEnt ImmunoGen Inc NASDAQ: $IMGN #Drug Health Care : Biotechnology | Small Cap BlendCompany profile BuySell Closing Price $2.25 July 4th 2019, 10:07am |
|
@Gambiste1 RT @sheldoncrasto88: https://t.co/eeTI6ILW49 Verified $20.08 profit in $IMGN bought this dip buy July 2nd 2019, 10:07pm |
 |
@sheldoncrasto88 https://t.co/eeTI6ILW49 Verified $20.08 profit in $IMGN bought this dip buy July 2nd 2019, 8:07pm |
 |
@SwingTradeBot 50 DMA Support today: $IMGN ... https://t.co/aW7zteKP9U July 2nd 2019, 3:07pm |
 |
@InsiderAlertsIA $IMGN: New Insider Filing on Executive VP, General Counsel CRAIG BARROWS: https://t.co/yCpB8ASOUq July 2nd 2019, 1:07pm |
 |
@StockTexts $IMGN ImmunoGen, Inc. SEC Filing: Form 4 https://t.co/S3cleUCJC9 July 2nd 2019, 1:07pm |
 |
@FlashAlert_me $IMGN filed SEC form 4: VP & Chief Medical Officer Berkenblit Anna: Bought 5230 of Common Stock at price 1.84 on 2… https://t.co/NZ8vCaCJTy July 2nd 2019, 1:07pm |
|
@FlashAlert_me $IMGN filed SEC form 4: Chief Executive Officer Enyedy Mark J: Bought 5230 of Common Stock at price 1.84 on 2019-0… https://t.co/wu0lIWFydA July 2nd 2019, 1:07pm |
|
@FlashAlert_me $IMGN filed SEC form 4: VP, Technical Operations Ryll Thomas: Bought 5230 of Common Stock at price 1.84 on 2019-07… https://t.co/L9EBbGdTpX July 2nd 2019, 1:07pm |
|
@FlashAlert_me $IMGN filed SEC form 4: V.P.-Fin., Prin. Acctg. Off. FOSTER DAVID G: Bought 3536 of Common Stock at price 1.84 on… https://t.co/Y563evfc3y July 2nd 2019, 1:07pm |
|
@FlashAlert_me $IMGN filed SEC form 4: EVP & Chief Business Officer McKee Blaine H.: Bought 5230 of Common Stock at price 1.84 on… https://t.co/flukvU5HY9 July 2nd 2019, 1:07pm |
|
@FlashAlert_me $IMGN filed SEC form 4: Executive VP, General Counsel BARROWS CRAIG: Bought 5230 of Common Stock at price 1.84 on… https://t.co/NAGrD6ZuRi July 2nd 2019, 1:07pm |
 |
@finzine $ATRA $IMGN Citi Finds Biotech Executives Jump Ship Ahead of Bad Drug Trials via https://t.co/dU2ohMb1g7 July 2nd 2019, 10:07am |
 |
@ConsumerFeed ImmunoGen $IMGN Given a $4.00 Price Target by HC Wainwright Analysts https://t.co/vr0OQsYtKx July 2nd 2019, 6:07am |
 |
@StockSpotter $IMGN up 5.5% to 2.29 since our bullish alert Fri. Jun 28 after the bell #swingtrading https://t.co/g8QEozplp6 July 1st 2019, 2:07pm |
 |
@SolarMelt $IMGN In the failed FORWARD-I trial, Mirvetuximab Soravtansine achieved some promising results in high FRa expressi… https://t.co/CMJI30doLN July 1st 2019, 1:07pm |
|
@SolarMelt $IMGN A fresh P3 trial of Mirvetuximab Soravtansine (Ovarian Cancer) is expected to begin by year end. This follows… https://t.co/1QSxmwlGJM July 1st 2019, 1:07pm |
|
@InsiderAlertsIA $IMGN: New Insider Filing on Director DEAN J MITCHELL: https://t.co/hXsoWFukjV July 1st 2019, 10:07am |
 |
@iamtito_ $IMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/qXM2AlWz7U July 1st 2019, 9:07am |
|
@iamtito_ $IMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/3PrMATPJyZ July 1st 2019, 9:07am |
|
@FlashAlert_me $IMGN filed SEC form 4: Director MITCHELL DEAN J: https://t.co/Sncl59WE5x July 1st 2019, 9:07am |
|
@FlashAlert_me $IMGN filed SEC form 4: Director Goldberg Mark Alan: https://t.co/tbvDB0BirT July 1st 2019, 9:07am |
 |
@TranscriptDaily HC Wainwright Analysts Give ImmunoGen $IMGN a $4.00 Price Target https://t.co/yp8VAUMlr6 July 1st 2019, 4:07am |
|
@TranscriptDaily ImmunoGen $IMGN Receives “Buy” Rating from Cowen https://t.co/NG8SJi01tp July 1st 2019, 3:07am |
|
@ThisLincolnian ImmunoGen $IMGN Given “Buy” Rating at Cowen https://t.co/ztb9wEGgw2 June 30th 2019, 7:06am |
|
@WeekHerald ImmunoGen $IMGN Earns “Buy” Rating from Cowen https://t.co/e2R2nFWHP7 June 30th 2019, 7:06am |
|
@OlympiaReport ImmunoGen $IMGN Downgraded to “Strong Sell” at BidaskClub https://t.co/Q0PPD2va5Y June 30th 2019, 1:06am |
|
@WeekHerald ImmunoGen $IMGN Downgraded to “Strong Sell” at BidaskClub https://t.co/OD36pHbOBY June 30th 2019, 1:06am |
|
@ThisLincolnian ImmunoGen $IMGN Downgraded to “Strong Sell” at BidaskClub https://t.co/CTdO4q7Cc1 June 30th 2019, 1:06am |
|
@TheMarketsDaily ImmunoGen, Inc. $IMGN Expected to Post Quarterly Sales of $10.33 Million https://t.co/jDZzRAzMOo June 30th 2019, 12:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.